Osteoporosis pp 271-274 | Cite as

Bone Mass in Renal Disease

  • Paul D. Miller
Part of the Current Clinical Practice book series (CCP)

Abstract

Renal metabolic bone disease is a heterogenous group of bone disorders, some delineated as distinct entities, each of which has distinct pathophysiological mechanisms, and other, often interlinked mechanisms, which are incompletely understood (Table 1).

Keywords

Osteoporosis Rosen Nephritis Hyperparathyroidism Hypercalcemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Malluche HH, Faugere M-C. Renal bone disease 1990: An unmet challenge for the nephrologist.Kidney Int1990; 38: 193–211.PubMedCrossRefGoogle Scholar
  2. 2.
    Pei Y, Hercz G, Greenwood C, et al. Risk factors for renal osteodystrophy.JBone Miner Res1995; 10: 149–156.CrossRefGoogle Scholar
  3. 3.
    Hutchison A, Whitehouse RW, Boulton HF, et al. Correlation of bone histology with parathyroid hormone, Vitamin D and radiology in end-stage renal disease.Kidney Int1993; 44: 1071–1077.PubMedCrossRefGoogle Scholar
  4. 4.
    Malluche HH, Monier-Faugere M-C. The role of bone biopsy in the management of patients with renal osteodystrophy.JAm Soc Nephrol1994; 41: 1631–1642.Google Scholar
  5. 5.
    Gabay C, Rvedin P, Slosman D, et al. Bone mineral density in patient with end-stage renal disease.Am J Nephrol1993 13: 115–123.CrossRefGoogle Scholar
  6. 6.
    Copley JB, Hui SL, Leapman S, Slemenda CW, Johnston CC. Longitudinal study of bone mass in end-stage renal disease patients: Effects of parathyroidectomy for renal osteodystrophy.J Bone Miner Res1993; 8: 415–422.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Paul D. Miller

There are no affiliations available

Personalised recommendations